OUTCOMES OF COMMERCIAL AND IN-HOUSE ANTI CD19 CAR T-CELL THERAPY FOR RELAPSED/REFRACTORY B-CELL LYMPHOMA IN SINGAPORE

被引：0
|
作者：
Ong, Shin Yeu [1 ]
Krisnadi, Cindy [1 ]
Wang, Samuel Sherng Young [1 ]
Chen, Yun Xin [1 ]
Seng, Michaela Su-fern [2 ]
Soh, Shui Yen [2 ]
Chan, Esther Hian Li [3 ]
Hwang, William Ying Khee [1 ]
Ho, Aloysius Yew Leng [1 ]
Lim, Francesca Lorraine Wei Inng [1 ]
机构：
[1] Singapore Gen Hosp, Singapore, Singapore
[2] KK Womens & Childrens Hosp, Singapore, Singapore
[3] Natl Univ Canc Inst, Singapore, Singapore
来源：
BONE MARROW TRANSPLANTATION | 2024年 / 59卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P120
引用
收藏
页码：226 / 226
页数：1
相关论文
共 50 条
  • [31] Timing of PD-L1 Blockade with Durvalumab May Affect Outcomes of CD19 CAR-T Cell Therapy for Relapsed/Refractory Large B-Cell Lymphoma
    Hirayama, Alexandre Vinaud
    Fiorenza, Salvatore
    Gauthier, Jordan
    Voutsinas, Jenna M.
    Wu, Qian Vicky
    Kimble, Erik L.
    Pender, Barbara S.
    Kirchmeier, Delaney R.
    Di, Henna A.
    Cassaday, Ryan D.
    Chapuis, Aude G.
    Green, Damian J.
    Kiem, Hans-Peter
    Milano, Filippo
    Shadman, Mazyar
    Till, Brian G.
    Riddell, Stanley R.
    Maloney, David G.
    Turtle, Cameron J.
    BLOOD, 2022, 140 : 7447 - 7449
  • [32] A CD19/CD20-Directed Bispecific CAR-T Cell Therapy in Relapsed or Refractory Aggressive B-Cell Non-Hodgkin Lymphoma (NHL)
    Larson, Sarah M.
    Chen, Yvonne Y.
    Johnston, Jim
    Roy, Sylvain
    Patel, Pinakin
    Benjamin, Jonathan E.
    BLOOD, 2023, 142
  • [33] Outcomes among adult recipients of CD19 CAR T-cell therapy for Burkitt lymphoma
    Samples, Laura S.
    Sadrzadeh, Hossein
    Frigault, Matthew J.
    Jacobson, Caron Alyce
    Hamadani, Mehdi
    Gurumurthi, Ashwath
    Strati, Paolo
    Shouval, Roni
    Riedell, Peter A.
    Dahiya, Saurabh
    Yared, Jean
    Jain, Michael D.
    Locke, Frederick L.
    Leslie, Lori Ann
    Epperla, Narendranath
    Ghosh, Monalisa
    Skarbnik, Alan
    Hill, Brian T.
    Kamdar, Manali K.
    Shadman, Mazyar
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [34] Proton Therapy as a Bridging Treatment in CAR T-Cell Therapy for Relapsed and Refractory Large B-Cell Lymphoma: Is There a Role?
    Saifi, Omran
    Kharfan-Dabaja, Mohamed A.
    Zeidan, Youssef H.
    Peterson, Jennifer
    Rule, William G.
    Lester, Scott C.
    Hoppe, Bradford S.
    INTERNATIONAL JOURNAL OF PARTICLE THERAPY, 2020, 7 (01) : 13 - 20
  • [35] Axicabtagene Ciloleucel (Axi-cel) CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory Large B-Cell Lymphoma: Real World Experience
    Nastoupil, Loretta J.
    Jain, Michael D.
    Spiegel, Jay Y.
    Ghobadi, Armin
    Lin, Yi
    Dahiya, Saurabh
    Lunning, Matthew A.
    Lekakis, Lazaros J.
    Reagan, Patrick M.
    Oluwole, Olalekan O.
    McGuirk, Joseph P.
    Deol, Abhinav
    Sehgal, Alison R.
    Goy, Andre
    Hill, Brian T.
    Andreadis, Charalambos
    Munoz, Javier
    Westin, Jason R.
    Chavez, Julio C.
    Cashen, Amanda F.
    Bennani, Nora N.
    Rapoport, Aaron P.
    Vose, Julie M.
    Miklos, David B.
    Neelapu, Sattva S.
    Locke, Frederick L.
    BLOOD, 2018, 132
  • [36] Salvage Radiotherapy in Relapsed/ Refractory Large B-Cell Lymphoma After CAR T-Cell Therapy Failure
    Ababneh, Hazim
    Ng, Andrea
    Frigault, Matthew
    Abramson, Jeremy
    Johnson, Patrick
    Jacobson, Caron
    Patel, Chirayu
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S414 - S414
  • [37] Efficacy and safety of chimeric antigen receptor T-cell therapy targeting CD19/CD22 in refractory/relapsed transformed aggressive B-cell lymphoma
    Xu, Hao
    Lv, Qiuxia
    Huang, Liang
    Cao, Wenyue
    Wang, Jue
    Meng, Fankai
    Li, Chunrui
    Zheng, Miao
    Chen, Liting
    Mu, Ketao
    Cheng, Jiali
    Zhu, Li
    Zhou, Jianfeng
    Zhang, Yicheng
    Wang, Na
    Cao, Yang
    CYTOTHERAPY, 2023, 25 (02) : 185 - 191
  • [38] Salvage radiotherapy in relapsed/refractory large B-cell lymphoma after failure of CAR T-cell therapy
    Ababneh, Hazim S.
    Ng, Andrea K.
    Frigault, Matthew J.
    Abramson, Jeremy S.
    Johnson, Patrick Connor
    Jacobson, Caron A.
    Patel, C. G.
    HAEMATOLOGICA, 2023, 108 (11) : 2972 - 2981
  • [39] Factors Predicting Long-Term Survival Following CD19 CAR T-Cell Therapy in Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia
    Zhang, Xian
    Yang, Junfang
    Li, Wenqian
    Zhang, Gailing
    Su, Yunchao
    Shi, Yanze
    Song, Dan
    Zhang, Min
    He, Jiujiang
    Xu, Li
    Li, Jingjing
    Lu, Xinan
    Li, Jianqiang
    Li, Xiangqun
    Xu, Zhongwei
    Li, Ziyu
    Lu, Peihua
    BLOOD, 2020, 136
  • [40] Dendritic cell vaccines extend CAR T-cell persistence and improve the efficacy of CD19 CAR T-cell therapy in refractory or relapsed adult B-ALL patients
    Tu, Sanfang
    Zhou, Lijuan
    Huang, Rui
    Zhou, Xuan
    Yang, Jilong
    He, Yanjie
    Hu, Yuxing
    Zhang, Honghao
    Xie, Xiaoling
    Li, Yuhua
    AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 (07) : 1437 - 1440
12345